Hematology and Oncology UCSF Health

David A. Tuveson MD, PhD

David Tuveson is Director of the Cancer Center and the Roy J. Zuckerberg Professor of Cancer Research at Cold Spring Harbor Laboratory, and the Chief Scientist at the Lustgarten Foundation.  Dr. Tuveson obtained a bachelors degree in chemistry at M.I.T., followed by M.D. and Ph.D. degrees at Johns Hopkins. Dr. Tuveson was a medical resident at Brigham and Women’s Hospital and a medical oncology fellow at Dana-Farber/Harvard Cancer Center.  During his post-doctoral years in Boston, Dr. Tuveson co-developed KIT inhibitors for gastrointestinal stromal tumors with George Demetri.  Simultaneously, he generated several widely-used mouse cancer models with Tyler Jacks.  As an independent investigator, his lab developed the first mouse models of ductal pancreatic cancer at the University of Pennsylvania.  Subsequently, Dr. Tuveson was recruited to the University of Cambridge where his lab identified poor drug delivery as a barrier for therapeutic efficacy in pancreatic cancer.  He was then recruited to CSHL as the Deputy Director of the Cancer Center and to serve as Director of Research for the Lustgarten Foundation.  At CSHL, his lab co-developed pancreatic organoid cancer models with Hans Clevers, and made a series of observations regarding cancer fibroblasts, redox regulation, and pancreatitis. His awards include the Rita Allen Scholarship and the Jan Waldenström Award, and the Hamdan Award.

PLEASE NOTE THAT THIS GRAND ROUNDS IS BEING HELD IN COLE HALL, NOT HSW-301 

To access MGR live streams and current semester recordings, please visit ETS here: DOM Medical Grand Rounds.

Objectives:

• Review updates in the management of breast cancer
• Incorporating genomic data in breast cancer management
• New therapies and paradigms in breast cancer management
• Discuss the landscape of breast cancer in San Francisco

Robert M. Wachter, MD is Professor and Chair of the Department of Medicine at the University of California, San Francisco, where he is the Holly Smith Distinguished Professor in Science and Medicine and the Benioff Endowed Chair in Hospital Medicine. The department leads the nation in NIH grants and is generally ranked as one of the nation’s best.

Wachter is author of 250 articles and 6 books and is a frequent contributor to the New York Times and Wall Street Journal. He coined the term “hospitalist” in 1996 and is often considered the “father” of the hospitalist field, the fastest growing specialty in the history of modern medicine. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine.

In the safety and quality arenas, he edits the U.S. government’s leading website on patient safety and has written two books on the subject, including Understanding Patient Safety, the world’s top selling safety primer. In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. Twelve times, Modern Healthcare magazine has ranked him as one of the 50 most influential physician-executives in the U.S.; he was #1 on the list in 2015. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age, was a New York Times science bestseller. In 2016, he chaired a blue-ribbon commission advising England’s National Health Service on its digital strategy.

.To access MGR live streams and current semester recordings, please visit ETS here: DOM Medical Grand Rounds.

Lawrence Fong is a Professor in Residence in the Division of Hematology/Oncology.

To access MGR live streams and current semester recordings, please visit ETS here: DOM Medical Grand Rounds.